Industries Healthcare and Life Sciences Technology

Healthcare technology diligence that tests the evidence, not the slide

Diligence across healthcare IT, digital health, revenue cycle, and life sciences platforms.

Healthcare platforms carry two burdens at once: they must protect sensitive patient data, and they must integrate with EHRs, payers, labs, and devices they don’t control. Buyers often inherit risk that only shows up after close, in a breach, a failed integration, or a compliance claim that doesn’t hold. We assess whether the architecture, team, and controls actually support the product’s intended use and growth plan.

What we find most often in healthcare deals

  1. Security below what PHI requires.

    No penetration testing, web application firewall, intrusion detection, or code scanning, and SOC 2 not yet started, which puts enterprise health system, pharma, and payer deals at least a year away after close.

  2. Untested disaster recovery for a regulated platform.

    Everything in one cloud region, no validated recovery targets, and a recovery plan that has never been exercised.

  3. One database, one failure.

    All services share a single database, so one database incident takes the whole platform down with no degraded mode. We recommend fault isolation (AKF’s swim lanes) between clinical and non-clinical functions, and a Z-axis split on the AKF Scale Cube for the customer or geographic data isolation that state-level compliance and enterprise partners will ask for.

  4. Every release carries full-platform risk.

    The backend deploys as one unit with no blue/green or canary releases, so each change can affect every patient-facing workflow.

  5. Clinical AI that is promising but ungoverned.

    The strongest teams use human review and structured prompt management; the gaps are drift monitoring, guardrails, and evaluation that would satisfy an enterprise partner.

  6. Fragile EHR dependencies.

    Custom workflows built around an EHR or practice management system through unsupported integrations that break when the vendor changes something. We assess the replacement plan and put a cost and timeline on it with a technical debt balance sheet.

  7. Key-person concentration.

    One technology leader holding architecture, security, AI, and infrastructure, with no succession plan.

Get Started

Evaluating a healthcare technology company?

Get a read from a team that has assessed healthcare platforms before.